476 related articles for article (PubMed ID: 11437089)
1. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 2: Preliminary UK estimates of prevalent injection-related hepatitis C carriers, and derivation of progression rates to liver cirrhosis by gender and age at hepatitis C virus infection.
Bird SM; Goldberg DJ; Hutchinson SJ
J Epidemiol Biostat; 2001; 6(3):267-77; discussion 279-85. PubMed ID: 11437089
[TBL] [Abstract][Full Text] [Related]
2. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
Bird SM; Goldberg DJ; Hutchinson SJ
J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
[TBL] [Abstract][Full Text] [Related]
3. Modelling the hepatitis C virus epidemic in Australia. Hepatitis C Virus Projections Working Group.
Law MG
J Gastroenterol Hepatol; 1999 Nov; 14(11):1100-7. PubMed ID: 10574138
[TBL] [Abstract][Full Text] [Related]
4. Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001.
Law MG; Dore GJ; Bath N; Thompson S; Crofts N; Dolan K; Giles W; Gow P; Kaldor J; Loveday S; Powell E; Spencer J; Wodak A
Int J Epidemiol; 2003 Oct; 32(5):717-24. PubMed ID: 14559738
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis C virus-related complications are increasing in women veterans: A national cohort study.
Kramer JR; El-Serag HB; Taylor TJ; White DL; Asch SM; Frayne SM; Cao Y; Smith DL; Kanwal F
J Viral Hepat; 2017 Nov; 24(11):955-965. PubMed ID: 28815822
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus infection in Scotland: epidemiological review and public health challenges.
Hutchinson SJ; Roy KM; Wadd S; Bird SM; Taylor A; Anderson E; Shaw L; Codere G; Goldberg DJ
Scott Med J; 2006 May; 51(2):8-15. PubMed ID: 16722130
[TBL] [Abstract][Full Text] [Related]
7. Natural histories of hepatitis C virus infection in men and women simulated by the Markov model.
Tanaka J; Kumada H; Ikeda K; Chayama K; Mizui M; Hino K; Katayama K; Kumagai J; Komiya Y; Miyakawa Y; Yoshizawa H
J Med Virol; 2003 Jul; 70(3):378-86. PubMed ID: 12767000
[TBL] [Abstract][Full Text] [Related]
8. Hepatitis C virus infection in chronic liver disease in Natal.
Soni PN; Tait DR; Gopaul W; Sathar MA; Simjee AE
S Afr Med J; 1996 Jan; 86(1):80-3. PubMed ID: 8685789
[TBL] [Abstract][Full Text] [Related]
9. Enhanced antiviral treatment efficacy and uptake in preventing the rising burden of hepatitis C-related liver disease and costs in Australia.
Sievert W; Razavi H; Estes C; Thompson AJ; Zekry A; Roberts SK; Dore GJ
J Gastroenterol Hepatol; 2014 Aug; 29 Suppl 1():1-9. PubMed ID: 25055928
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of hepatitis C: related hepatocellular carcinoma in Cameroon.
Andoulo FA; Noah DN; Djapa R; Kowo M; Talla P; Medjo EH; Djomkam IK; Nonga BN; Njoya O; Ndam EC
Pan Afr Med J; 2014; 19():379. PubMed ID: 25977742
[TBL] [Abstract][Full Text] [Related]
11. The importance of HCV on the burden of chronic liver disease in Italy: a multicenter prevalence study of 9,997 cases.
Sagnelli E; Stroffolini T; Mele A; Almasio P; Coppola N; Ferrigno L; Scolastico C; Onofrio M; Imparato M; Filippini P
J Med Virol; 2005 Apr; 75(4):522-7. PubMed ID: 15714480
[TBL] [Abstract][Full Text] [Related]
12. HCV synthesis project: preliminary analyses of HCV prevalence in relation to age and duration of injection.
Hagan H; Des Jarlais DC; Stern R; Lelutiu-Weinberger C; Scheinmann R; Strauss S; Flom PL
Int J Drug Policy; 2007 Oct; 18(5):341-51. PubMed ID: 17854721
[TBL] [Abstract][Full Text] [Related]
13. Modelling the impact of improving screening and treatment of chronic hepatitis C virus infection on future hepatocellular carcinoma rates and liver-related mortality.
Cramp ME; Rosenberg WM; Ryder SD; Blach S; Parkes J
BMC Gastroenterol; 2014 Aug; 14():137. PubMed ID: 25100159
[TBL] [Abstract][Full Text] [Related]
14. Epidemic hepatitis C virus infection in Egypt: estimates of past incidence and future morbidity and mortality.
Lehman EM; Wilson ML
J Viral Hepat; 2009 Sep; 16(9):650-8. PubMed ID: 19413698
[TBL] [Abstract][Full Text] [Related]
15. Hepatic and extra-hepatic sequelae, and prevalence of viral hepatitis C infection estimated from routine data in at-risk groups.
Faustini A; Colais P; Fabrizi E; Bargagli AM; Davoli M; Di Lallo D; Di Napoli A; Pezzotti P; Sorge C; Grillo R; Maresca C; Recchia O; Perucci CA;
BMC Infect Dis; 2010 Apr; 10():97. PubMed ID: 20403169
[TBL] [Abstract][Full Text] [Related]
16. Pilot study to estimate survivors to 1995 of 1983-1984 prevalent hepatitis C infections in Lothian patients who tested positive or negative for hepatitis B surface antigen in 1983-1984.
Gore SM; Brettle RP; Burns SM; Lewis SC
J Infect; 1998 Sep; 37(2):159-65. PubMed ID: 9821091
[TBL] [Abstract][Full Text] [Related]
17. Current status of hepatitis C virus infection in Korea.
Suh DJ; Jeong SH
Intervirology; 2006; 49(1-2):70-5. PubMed ID: 16166792
[TBL] [Abstract][Full Text] [Related]
18. Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome.
Alter HJ; Seeff LB
Semin Liver Dis; 2000; 20(1):17-35. PubMed ID: 10895429
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of hepatitis C virus infection in Australia.
Dore GJ; Law M; MacDonald M; Kaldor JM
J Clin Virol; 2003 Feb; 26(2):171-84. PubMed ID: 12600649
[TBL] [Abstract][Full Text] [Related]
20. Modelling the burden of hepatitis C infection among people who inject drugs in Norway, 1973-2030.
Meijerink H; White RA; Løvlie A; de Blasio BF; Dalgard O; Amundsen EJ; Melum E; Kløvstad H
BMC Infect Dis; 2017 Aug; 17(1):541. PubMed ID: 28774261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]